Controversy surrounding the Sputnik V vaccine
- 9 August 2021
- journal article
- review article
- Published by Elsevier BV in Respiratory Medicine
- Vol. 187, 106569
- https://doi.org/10.1016/j.rmed.2021.106569
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineThe New England Journal of Medicine, 2020
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UKThe Lancet, 2020
- Use of adenovirus type-5 vectored vaccines: a cautionary taleThe Lancet, 2020
- Safety and efficacy of the Russian COVID-19 vaccine: more information neededThe Lancet, 2020
- Safety and efficacy of the Russian COVID-19 vaccine: more information needed – Authors’ replyThe Lancet, 2020
- Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from RussiaThe Lancet, 2020
- Pharmacological management of COVID-19 patients with ARDS (CARDS): A narrative reviewRespiratory Medicine, 2020
- Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trialThe Lancet, 2020
- International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populationsVaccine, 2011
- Activation of a dendritic cell–T cell axis by Ad5 immune complexes creates an improved environment for replication of HIV in T cellsThe Journal of Experimental Medicine, 2008